1. Tersmette AC, Petersen GM, Offerhaus GJ, et al. Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res. 2001;7:738–744.
2. Eberle MA, Pfutzer R, Pogue-Geile KL, et al. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32–34. Am J Hum Genet. 2002;70:1044–1048.
3. van der Heijden MS, Yeo CJ, Hruban RH, Kern SE. Fanconianemia gene mutations in young-onset pancreatic cancer. Cancer Res. 2003;63:2585–2588.
4. Cox B, Waisfisz Q, Die-Smulders C, et al. Biallelic inactivation of BRCA2 in fanconianemia. Science. 2002;297:606–609.
5. Murphy KM, Brune KA, Griffin C, et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%. Cancer Res. 2002;62:3789–3793.